Bart Rossel is Scientific Advisor and Advisory Board Member for the Novalis Biotech Incubation Fund. Bart is also member of the Supervisory Board of Novalis.
Bart Rossel (°1971) is a director of companies, entrepreneur and inventor in the consumer health care business. Educated as a bio-engineer, Bart has held several management positions in the agro and life science business. In 2002, Bart and his team acquired the pharmaceutical company Oystershell Laboratories, which was sold in 2017 to Gilde Buy Out Partners. Oystershell licenses and grants distribution rights on dozens of inventions in OTC fields such as wound care, pediatrics, anti-insect treatment, oral care and dermatology. Bart holds several patents to his name.
He is also the author of The Marvellous Book of Insects (Le merveilleux Livre des Insectes, Het Wonderlijke Insectenboek, Lannoo 2017)
Specialties: